1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

About 300 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030 ##.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • Japan

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

  • $ 22000
  • January 2019
  • 510 pages

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026 CONTENTS ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • United States

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence

  • $ 22000
  • October 2018
  • 475 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence Table of Contents (Forecast, Treatment, Epidemiology Datapacks included) ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## October 2018) ## OVERVIEW ## RECENT FORECAST UPDATES

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • United States

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • April 2018
  • 229 pages

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 196 pages

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment and Epidemiology Datapacks included) & nbsp; ## FORECAST: MANTLE CELL LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • Japan

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 162 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## August 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVE

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Aliqopa

  • $ 10000
  • January 2019
  • 18 pages

Aliqopa CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Aliqopa : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Aliqopa for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Aliqopa for follicular

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • Japan

lisocabtagene maraleucel

  • $ 10000
  • January 2019
  • 30 pages

lisocabtagene maraleucel CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## lisocabtagene maraleucel : NHL: Follicular lymphoma (FL) ## lisocabtagene maraleucel : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Lisocabtagene maraleucel for follicula

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Pathology
  • Japan

Yescarta

  • $ 10000
  • January 2019
  • 19 pages

Yescarta CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Yescarta : NHL: Follicular lymphoma (FL) ## Yescarta : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Yescarta for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor H

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Japan

Revlimid

  • $ 10000
  • January 2019
  • 56 pages

Revlimid CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Revlimid : NHL: Follicular lymphoma (FL) ## Revlimid : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Revlimid : Multiple myeloma ## Revlimid : NHL: Mantle cell lymphoma (MCL) LIST OF FIGURES ## Figur

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • Japan

NHL: Diffuse large Bcell lymphoma

  • $ 5000
  • May 2016
  • 219 pages

Immunophenotyping also needs to be robust enough to distinguish the disease from other lymphomas which resemble DLBCL in morphology, such as mantle cell lymphoma and Burkitt' s lymphoma.

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Japan

NHL: Follicular lymphoma

  • $ 5000
  • April 2016
  • 252 pages

NHL: Follicular lymphoma Disease Coverage | Treatment: Follicular Lymphoma practices.

  • Healthcare
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Japan

NHL: Mantle cell lymphoma

  • $ 5000
  • April 2016
  • 214 pages

Lymphoma Association (2016) Mantle cell lymphoma.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Japan

polatuzumab vedotin

  • $ 10000
  • October 2018
  • 18 pages

polatuzumab vedotin CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## polatuzumab vedotin : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Polatuzumab vedotin for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Japan

Selinexor

  • $ 10000
  • October 2018
  • 32 pages

Selinexor CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## selinexor : NHL: Diffuse large B-cell lymphoma (DLBCL) ## selinexor : Multiple myeloma LIST OF FIGURES ## Figure ##: Selinexor for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcar

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Blincyto

  • $ 10000
  • October 2018
  • 25 pages

Blincyto CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Blincyto : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Blincyto : Acute lymphoblastic leukemia (ALL) LIST OF FIGURES ## Figure ##: Blincyto for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamon

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Japan

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 212 pages

BAY-##, AN ORAL ATR INHIBITOR, IS BEING INVESTIGATED IN A PHASE I STUDY (BAYER, NCT##) IN SOLID TUMORS (INCLUDING PCA) AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Prostate Cancer
  • Therapy
  • Japan

Bavencio

  • $ 10000
  • October 2018
  • 82 pages

Bavencio CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Bavencio : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Bavencio : Non-small cell lung cancer (NSCLC) ## Bavencio : Gastric cancer ## Bavencio : Head and neck cancer ## Bavencio : Ovarian cancer ## Bavencio : Bladde

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • Japan

Transthyretin Amyloidosis - Global Drug Forecast and Market Analysis to 2029

  • $ 10995
  • June 2020
  • 129 pages

AMYLOIDOSIS MAY APPEAR IN CONJUNCTION WITH OR AS A RESULT OF THE FOLLOWING DISORDERS: MULTIPLE MYELOMA, HODGKIN' S LYMPHOMA, LYMPHOMA, MEDULLARY CARCINOMA OF THE THYROID, WHIPPLE DISEASE, CROHN' S DISEASE, OSTEOMYELITIS, RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, REITER NATIONAL

  • Antimalarials
  • Endocrine Disease
  • Lymphoma
  • Japan
  • Pfizer Inc.

Multiple Myeloma: Epidemiology Forecast to 2027

  • $ 3995
  • March 2019
  • 42 pages

The Leukemia and Lymphoma Society (2015) Myeloma.

  • Cancer
  • Lymphoma
  • Japan
  • United States
  • Forecast
View report >

Lymphoma Statistics in Japan - Forecast

  • April 2019
  • 19 pages

In the case of Japanese patients, malignant lymphomas are mostly (##%) of the NHL type.

  • Lymphoma
  • Japan
  • Astellas Pharma Inc.
  • Onconova Therapeutics, Inc.
  • SymBio Pharmaceuticals Limited

Global Oncology Market October 2018

Cancer Statistics July 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on